Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/26854
Title: Reflux disease: The view of the internist.
Authors: Hansky J.
Institution: (Hansky) Gastroenterology Unit, Monash Medical Centre, Clayton, Vic., Australia (Hansky) Gastroenterology Unit, Monash Medical Centre, Victoria, 246 Clayton Road, Clayton, Vic. 3168, Australia
Issue Date: 2-Nov-1996
Copyright year: 1996
Publisher: Taylor and Francis A.S. (P.O. Box 2562 Solli, Oslo 0202, Norway)
Taylor and Francis A.S.
Place of publication: Norway
Publication information: Scandinavian Journal of Gastroenterology, Supplement. 31 (220) (pp 63-65), 1996. Date of Publication: 1996.
Journal: Scandinavian Journal of Gastroenterology, Supplement
Abstract: Pathogenesis of GERD is mainly concerned with a defective antireflux barrier to gastric and duodenal contents. Transient lower oesophageal sphincter relaxation is thought to be the main mechanism by which reflux is permitted, but the mucosal exposure time to the refluxate, the nature of the refluxed material and oesophageal clearance are important mechanisms. The internist only sees the 'tip of the iceberg' as far as GERD is concerned, and generally these are severe resistant cases of GERD. In this group, endoscopy is mandatory to assessing degree of inflammation and treatment is generally with proton-pump inhibitors, which have made the therapy of GERD relatively easy. Although treatment is effective, problems relating to safety of long-term profound gastric acid suppression, cost and effect on quality of life remain to be resolved.
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.3109/00365529609094752
Link to associated publication: Click here for full text options
PubMed URL: 8898438 [http://www.ncbi.nlm.nih.gov/pubmed/?term=8898438]
ISSN: 0085-5928
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/26854
Type: Conference Paper
Subjects: *reflux esophagitis/di [Diagnosis]
*reflux esophagitis/dt [Drug Therapy]
*reflux esophagitis/et [Etiology]
stomach acid secretion
stomach cancer
*cisapride/dt [Drug Therapy]
*histamine H2 receptor antagonist/dt [Drug Therapy]
lansoprazole/dt [Drug Therapy]
omeprazole/dt [Drug Therapy]
*proton pump inhibitor/dt [Drug Therapy]
*sucralfate/dt [Drug Therapy]
*reflux esophagitis/su [Surgery]
antireflux operation
conference paper
endoscopy
esophagus pH
*gastroesophageal reflux/di [Diagnosis]
*gastroesophageal reflux/dt [Drug Therapy]
*gastroesophageal reflux/et [Etiology]
*gastroesophageal reflux/su [Surgery]
Helicobacter pylori
human
internal medicine
lower esophagus sphincter
maintenance therapy
priority journal
*gastroesophageal reflux / *diagnosis / *drug therapy / *etiology / *surgery
esophagus pH
endoscopy
conference paper
Helicobacter pylori
esophagus ph
helicobacter pylori
antireflux operation
human
internal medicine
lower esophagus sphincter
maintenance therapy
priority journal
*reflux esophagitis / *diagnosis / *drug therapy / *etiology / *surgery
stomach acid secretion
stomach cancer
Appears in Collections:Articles

Show full item record

Page view(s)

6
checked on Aug 18, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.